Michel D Ferrari Selected Research

Michel D Ferrari Research Topics

Disease

90	Migraine Disorders (Migraine) 05/2024 - 01/2002
37	Migraine with Aura (Familial Hemiplegic Migraine) 01/2023 - 09/2003
17	Epilepsy (Aura) 01/2023 - 01/2004
13	Headache (Headaches) 01/2020 - 02/2005
12	Pain (Aches) 01/2015 - 01/2002
10	Cluster Headache (Cluster Headaches) 12/2022 - 11/2013
6	Stroke (Strokes) 12/2019 - 02/2006
4	Migraine without Aura (Common Migraine) 01/2021 - 11/2008
4	Ischemic Stroke 10/2020 - 01/2012
4	CADASIL 01/2018 - 12/2010
3	Infarction (Infarctions) 10/2020 - 01/2012
3	Leukoencephalopathies 01/2018 - 11/2016
3	Ataxia (Dyssynergia) 01/2009 - 12/2006
2	Seizures (Absence Seizure) 01/2022 - 01/2009
2	visual snow syndrome 01/2021 - 07/2019
2	5 Familial Hemophagocytic Lymphohistiocytosis 01/2021 - 06/2016
2	Prescription Drug Overuse 01/2020 - 01/2019
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2018 - 12/2017
2	Cerebral Small Vessel Diseases 01/2018 - 12/2012
2	Disease Progression 01/2018 - 03/2002
2	Neuroinflammatory Diseases 08/2017 - 06/2017
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2017 - 01/2016
2	Inflammation (Inflammations) 01/2016 - 02/2013
2	Cerebellar Ataxia (Dysmetria) 03/2014 - 10/2012
2	Photophobia (Light Sensitivity) 08/2013 - 12/2008
2	Headache Disorders (Headache Syndromes) 07/2012 - 06/2005
2	Muscle Weakness 04/2007 - 03/2002
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Brain Edema (Cerebral Edema) 01/2022
1	Transient Ischemic Attack 10/2020
1	Ischemia 10/2020
1	Brain Ischemia (Cerebral Ischemia) 10/2020

Drug/Important Bio-Agent (IBA)

24	voltage-dependent calcium channel (P-Q type)IBA 01/2022 - 03/2004
11	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2006
9	Tryptamines (Triptans)IBA 01/2020 - 01/2003
9	Calcium Channels (Calcium Channel)IBA 01/2017 - 06/2002
8	Pain-FreeIBA 07/2012 - 02/2005
7	Glutamic Acid (Glutamate)FDA Link 01/2021 - 06/2007
7	Retinaldehyde (Retinal)IBA 01/2018 - 06/2008
7	frovatriptan (Allegro)FDA Link 07/2012 - 06/2010
6	Calcitonin Gene-Related PeptideIBA 10/2020 - 12/2008
5	Valproic Acid (Depakote)FDA LinkGeneric 01/2022 - 01/2010
5	zolmitriptan (Zomig)FDA Link 05/2012 - 12/2008
4	erenumabIBA 05/2024 - 11/2018
4	Type A Botulinum Toxins (Botox)FDA Link 01/2022 - 01/2019
4	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2022 - 10/2011
4	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2021 - 01/2020
4	Analgesics (Analgesic Drugs)IBA 01/2021 - 06/2005
4	Sumatriptan (Imigran)FDA LinkGeneric 01/2020 - 01/2002
4	Neurotransmitter Agents (Neurotransmitter)IBA 06/2017 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 06/2016 - 09/2012
4	Adenosine Triphosphatases (ATPase)IBA 09/2012 - 09/2003
4	almotriptan (Axert)FDA Link 07/2012 - 01/2002
4	rizatriptan (Maxalt)FDA Link 05/2012 - 01/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2007
3	Topiramate (Topamax)FDA LinkGeneric 01/2022 - 01/2010
3	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2014
3	salicylhydroxamic acid (SHAM)IBA 10/2019 - 01/2018
3	Lamotrigine (Lamictal)FDA LinkGeneric 07/2019 - 08/2014
3	telcagepantIBA 02/2016 - 12/2008
3	Hormones (Hormone)IBA 01/2015 - 02/2013
3	Vasoconstrictor AgentsIBA 10/2010 - 01/2004
3	PotassiumIBA 11/2008 - 06/2004
3	Sodium Channels (Sodium Channel)IBA 07/2008 - 07/2005
2	gamma-Aminobutyric Acid (GABA)IBA 01/2023 - 01/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 01/2015
2	Monoclonal AntibodiesIBA 01/2022 - 01/2016
2	fremanezumabIBA 01/2022 - 01/2019
2	Q-Type Calcium Channels (Q-Type Calcium Channel)IBA 01/2022 - 04/2014
2	Illicit Drugs (Recreational Drugs)IBA 01/2021 - 01/2019
2	Vasodilator Agents (Vasodilators)IBA 01/2020 - 01/2015
2	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 11/2018 - 12/2008
2	AndrogensIBA 01/2018 - 10/2009
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2018 - 02/2013
2	Capsaicin (Zostrix)FDA Link 01/2018 - 01/2015
2	IronIBA 07/2017 - 12/2012
2	Purinergic P2X3 ReceptorsIBA 01/2013 - 08/2010
2	Voltage-Gated Sodium ChannelsIBA 07/2008 - 07/2005
2	eletriptan (Relpax)FDA Link 02/2008 - 01/2002
1	tetraethylpyrazine (TEP)IBA 01/2023
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	AminesIBA 01/2023
1	3-methylmethcathinoneIBA 01/2021
1	Nitrous Oxide (Laughing Gas)IBA 01/2021
1	c-Mer Tyrosine KinaseIBA 01/2021
1	A 7 (A-7)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2021
1	Hallucinogens (Psychedelics)IBA 01/2021
1	4-fluoroamphetamineIBA 01/2021
1	Psilocybin (Psilocibin)IBA 01/2021
1	rimegepant sulfateIBA 10/2020
1	olcegepantIBA 10/2020
1	Oxygen (Dioxygen)IBA 01/2020

Therapy/Procedure

12	Therapeutics 12/2022 - 02/2005
4	Vagus Nerve Stimulation 10/2020 - 01/2018
2	Lasers (Laser) 01/2015 - 01/2012
1	Injections 02/2022